Leadership changes
Executive appointments and departures from SEC 8-K filings, updated within hours of each filing.
Updated Nov 6, 2026
Changes, November 2026
292
Appointments
143
Departures
34
Browse by role
Get new CFO appointments the day the filing lands.
Browse by month
Filters
3,420 changes
| Filing date | Company | Person | Role | Change | Effective date | Source |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | KIORA PHARMACEUTICALS INC | Keith Lane | Executive Vice President, Head of Clinical Development and Regulatory AffairsExecutive Vice President, Head of Clinical Development and Regulatory Affairs | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | Kura Oncology, Inc. | Jennifer Fulk | Chief Financial OfficerCFO | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | Laird Superfood, Inc. | Mark Johnson | Chief Financial OfficerCFO | Appointed | Oct 1, 2026 | SEC 8-K |
| Sep 8, 2026 | LASE Corp. | Timothy A. Peterman | Acting CFOCFO | Appointed | Sep 8, 2026 | SEC 8-K |
| Sep 8, 2026 | LIQTECH INTERNATIONAL INC | David Noerby Foss Kowalczyk | Chief Financial and Operating OfficerCFO | Departed | Nov 30, 2026 | SEC 8-K |
| Sep 8, 2026 | Mirum Pharmaceuticals, Inc. | Rob Myers, M.D. | Chief Medical OfficerCMO | Appointed | Sep 21, 2026 | SEC 8-K |
| Sep 8, 2026 | Mirum Pharmaceuticals, Inc. | Joanne Quan, M.D. | Chief Medical OfficerCMO | Departed | Sep 2, 2026 | SEC 8-K |
| Sep 8, 2026 | MNTN, Inc. | Michael J. Katz | Class II directorClass II director | Appointed | Sep 3, 2026 | SEC 8-K |
| Sep 8, 2026 | MSC INDUSTRIAL DIRECT CO INC | Robert Kuhns | Executive Vice President and Chief Financial OfficerCFO | Appointed | Sep 14, 2026 | SEC 8-K |
| Sep 8, 2026 | MSC INDUSTRIAL DIRECT CO INC | Greg Clark | Interim Chief Financial OfficerCFO | Departed | Sep 14, 2026 | SEC 8-K |
| Sep 8, 2026 | Nerdy Inc. | Kyle Callaway | Chief Accounting Officer and principal accounting officerChief Accounting Officer and principal accounting officer | Departed | n/a | SEC 8-K |
| Sep 8, 2026 | Nerdy Inc. | Atul Bagga | principal accounting officerprincipal accounting officer | Role change | n/a | SEC 8-K |
| Sep 8, 2026 | NORTHERN TECHNOLOGIES INTERNATIONAL CORP | Gautam Ramdas | President and Chief Executive OfficerCEO | Appointed | Sep 4, 2026 | SEC 8-K |
| Sep 8, 2026 | NORTHERN TECHNOLOGIES INTERNATIONAL CORP | G. Patrick Lynch | President and Chief Executive OfficerCEO | Departed | Sep 4, 2026 | SEC 8-K |
| Sep 8, 2026 | NORTHERN TECHNOLOGIES INTERNATIONAL CORP | G. Patrick Lynch | Chairman of the BoardChairman of the Board | Appointed | Sep 4, 2026 | SEC 8-K |
| Sep 8, 2026 | NORTHERN TECHNOLOGIES INTERNATIONAL CORP | Richard Nigon | lead independent directorlead independent director | Appointed | Sep 4, 2026 | SEC 8-K |
| Sep 8, 2026 | NORTHERN TECHNOLOGIES INTERNATIONAL CORP | Brian Haglund | Chief Operating OfficerCOO | Appointed | Sep 4, 2026 | SEC 8-K |
| Sep 8, 2026 | Offerpad Solutions Inc. | Benjamin Graboske | Class III directorClass III director | Appointed | Sep 3, 2026 | SEC 8-K |
| Sep 8, 2026 | Pyxis Oncology, Inc. | Thomas Civik | permanent Chief Executive OfficerCEO | Appointed | Sep 4, 2026 | SEC 8-K |
| Sep 8, 2026 | Pyxis Oncology, Inc. | John Flavin | Lead Independent DirectorLead Independent Director | Appointed | Sep 4, 2026 | SEC 8-K |
- KIORA PHARMACEUTICALS INCAppointed
Keith Lane Executive Vice President, Head of Clinical Development and Regulatory Affairs
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- Kura Oncology, Inc.Appointed
Jennifer Fulk CFO
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- Laird Superfood, Inc.Appointed
Mark Johnson CFO
Filed Sep 8, 2026Effective Oct 1, 2026SEC 8-K
- LASE Corp.Appointed
Timothy A. Peterman CFO
Filed Sep 8, 2026Effective Sep 8, 2026SEC 8-K
- LIQTECH INTERNATIONAL INCDeparted
David Noerby Foss Kowalczyk CFO
Filed Sep 8, 2026Effective Nov 30, 2026SEC 8-K
- Mirum Pharmaceuticals, Inc.Appointed
Rob Myers, M.D. CMO
Filed Sep 8, 2026Effective Sep 21, 2026SEC 8-K
- Mirum Pharmaceuticals, Inc.Departed
Joanne Quan, M.D. CMO
Filed Sep 8, 2026Effective Sep 2, 2026SEC 8-K
- MNTN, Inc.Appointed
Michael J. Katz Class II director
Filed Sep 8, 2026Effective Sep 3, 2026SEC 8-K
- MSC INDUSTRIAL DIRECT CO INCAppointed
Robert Kuhns CFO
Filed Sep 8, 2026Effective Sep 14, 2026SEC 8-K
- MSC INDUSTRIAL DIRECT CO INCDeparted
Greg Clark CFO
Filed Sep 8, 2026Effective Sep 14, 2026SEC 8-K
- Nerdy Inc.Departed
Kyle Callaway Chief Accounting Officer and principal accounting officer
Filed Sep 8, 2026SEC 8-K
- Nerdy Inc.Role change
Atul Bagga principal accounting officer
Filed Sep 8, 2026SEC 8-K
Gautam Ramdas CEO
Filed Sep 8, 2026Effective Sep 4, 2026SEC 8-K
G. Patrick Lynch CEO
Filed Sep 8, 2026Effective Sep 4, 2026SEC 8-K
G. Patrick Lynch Chairman of the Board
Filed Sep 8, 2026Effective Sep 4, 2026SEC 8-K
Richard Nigon lead independent director
Filed Sep 8, 2026Effective Sep 4, 2026SEC 8-K
Brian Haglund COO
Filed Sep 8, 2026Effective Sep 4, 2026SEC 8-K
- Offerpad Solutions Inc.Appointed
Benjamin Graboske Class III director
Filed Sep 8, 2026Effective Sep 3, 2026SEC 8-K
- Pyxis Oncology, Inc.Appointed
Thomas Civik CEO
Filed Sep 8, 2026Effective Sep 4, 2026SEC 8-K
- Pyxis Oncology, Inc.Appointed
John Flavin Lead Independent Director
Filed Sep 8, 2026Effective Sep 4, 2026SEC 8-K